Nalaganje...

Bimatoprost 0.01% vs bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patients

PURPOSE: To evaluate the safety of two commercially available formulations of bimatoprost eye drops: 0.03 and 0.01% ophthalmic solutions. METHODS: This was a randomized, prospective, parallel-group, open-label, cohort study. A total of 60 glaucoma patients (60 eyes) under bimatoprost 0.03% monothera...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Figus, M, Nardi, M, Piaggi, P, Sartini, M, Guidi, G, Martini, L, Lazzeri, S
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2014
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3983628/
https://ncbi.nlm.nih.gov/pubmed/24434659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2013.304
Oznake: Označite
Brez oznak, prvi označite!